Logo image of CYB.CA

CYMBRIA CORP-A (CYB.CA) Stock Price, Forecast & Analysis

Canada - Toronto Stock Exchange - TSX:CYB - CA23257X1096

87.01 CAD
+0.49 (+0.57%)
Last: 1/2/2026, 7:00:00 PM
Fundamental Rating

5

CYB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 80 industry peers in the Capital Markets industry. CYB has an excellent financial health rating, but there are some minor concerns on its profitability. CYB is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CYB had positive earnings in the past year.
CYB had a positive operating cash flow in the past year.
In multiple years CYB reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CYB reported negative operating cash flow in multiple years.
CYB.CA Yearly Net Income VS EBIT VS OCF VS FCFCYB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

CYB has a better Return On Assets (13.54%) than 82.50% of its industry peers.
The Return On Equity of CYB (14.67%) is better than 78.75% of its industry peers.
CYB has a Return On Invested Capital of 12.42%. This is amongst the best in the industry. CYB outperforms 83.75% of its industry peers.
Industry RankSector Rank
ROA 13.54%
ROE 14.67%
ROIC 12.42%
ROA(3y)5.85%
ROA(5y)6.63%
ROE(3y)6.35%
ROE(5y)7.09%
ROIC(3y)N/A
ROIC(5y)N/A
CYB.CA Yearly ROA, ROE, ROICCYB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

With an excellent Profit Margin value of 88.31%, CYB belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
CYB's Profit Margin has been stable in the last couple of years.
The Operating Margin of CYB (91.46%) is better than 93.75% of its industry peers.
In the last couple of years the Operating Margin of CYB has remained more or less at the same level.
CYB has a better Gross Margin (94.35%) than 88.75% of its industry peers.
In the last couple of years the Gross Margin of CYB has remained more or less at the same level.
Industry RankSector Rank
OM 91.46%
PM (TTM) 88.31%
GM 94.35%
OM growth 3Y-1.33%
OM growth 5Y-0.58%
PM growth 3Y-1.89%
PM growth 5Y-1.11%
GM growth 3Y-1.1%
GM growth 5Y-0.49%
CYB.CA Yearly Profit, Operating, Gross MarginsCYB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150 200

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, CYB has less shares outstanding
Compared to 5 years ago, CYB has less shares outstanding
CYB has a better debt/assets ratio than last year.
CYB.CA Yearly Shares OutstandingCYB.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CYB.CA Yearly Total Debt VS Total AssetsCYB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 6.88 indicates that CYB is not in any danger for bankruptcy at the moment.
CYB has a better Altman-Z score (6.88) than 83.75% of its industry peers.
CYB has a debt to FCF ratio of 0.76. This is a very positive value and a sign of high solvency as it would only need 0.76 years to pay back of all of its debts.
The Debt to FCF ratio of CYB (0.76) is better than 81.25% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that CYB is not too dependend on debt financing.
CYB's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. CYB outperforms 78.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.76
Altman-Z 6.88
ROIC/WACCN/A
WACCN/A
CYB.CA Yearly LT Debt VS Equity VS FCFCYB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 7.57 indicates that CYB has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.57, CYB belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
CYB has a Quick Ratio of 7.57. This indicates that CYB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 7.57, CYB belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.57
Quick Ratio 7.57
CYB.CA Yearly Current Assets VS Current LiabilitesCYB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

CYB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.64%.
CYB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.01% yearly.
The Revenue for CYB has decreased by -10.89% in the past year. This is quite bad
Measured over the past years, CYB shows a small growth in Revenue. The Revenue has been growing by 4.45% on average per year.
EPS 1Y (TTM)6.64%
EPS 3Y-6.38%
EPS 5Y4.01%
EPS Q2Q%26%
Revenue 1Y (TTM)-10.89%
Revenue growth 3Y-5.75%
Revenue growth 5Y4.45%
Sales Q2Q%19.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYB.CA Yearly Revenue VS EstimatesCYB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.63, the valuation of CYB can be described as very cheap.
Based on the Price/Earnings ratio, CYB is valued a bit cheaper than the industry average as 71.25% of the companies are valued more expensively.
CYB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.60.
Industry RankSector Rank
PE 6.63
Fwd PE N/A
CYB.CA Price Earnings VS Forward Price EarningsCYB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CYB is valued a bit cheaper than 77.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.59
EV/EBITDA N/A
CYB.CA Per share dataCYB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The decent profitability rating of CYB may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.65
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CYB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CYMBRIA CORP-A

TSX:CYB (1/2/2026, 7:00:00 PM)

87.01

+0.49 (+0.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-10 2025-11-10
Earnings (Next)03-26 2026-03-26
Inst Owners10.93%
Inst Owner ChangeN/A
Ins Owners0.49%
Ins Owner ChangeN/A
Market Cap1.36B
Revenue(TTM)323.78M
Net Income(TTM)285.94M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.63
Fwd PE N/A
P/S 4.21
P/FCF 20.59
P/OCF 20.59
P/B 0.7
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)13.12
EY15.08%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.23
FCFY4.86%
OCF(TTM)4.23
OCFY4.86%
SpS20.69
BVpS124.53
TBVpS124.53
PEG (NY)N/A
PEG (5Y)1.65
Graham Number191.74
Profitability
Industry RankSector Rank
ROA 13.54%
ROE 14.67%
ROCE 14.16%
ROIC 12.42%
ROICexc 13.3%
ROICexgc 13.3%
OM 91.46%
PM (TTM) 88.31%
GM 94.35%
FCFM 20.42%
ROA(3y)5.85%
ROA(5y)6.63%
ROE(3y)6.35%
ROE(5y)7.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-12.91%
ROICexgc growth 5Y-3.84%
ROICexc growth 3Y-12.91%
ROICexc growth 5Y-3.8%
OM growth 3Y-1.33%
OM growth 5Y-0.58%
PM growth 3Y-1.89%
PM growth 5Y-1.11%
GM growth 3Y-1.1%
GM growth 5Y-0.49%
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.76
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 78.21
Cash Conversion N/A
Profit Quality 23.13%
Current Ratio 7.57
Quick Ratio 7.57
Altman-Z 6.88
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.64%
EPS 3Y-6.38%
EPS 5Y4.01%
EPS Q2Q%26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.89%
Revenue growth 3Y-5.75%
Revenue growth 5Y4.45%
Sales Q2Q%19.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.18%
EBIT growth 3Y-7.01%
EBIT growth 5Y3.84%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y200.69%
FCF growth 3Y-16.31%
FCF growth 5Y-12.05%
OCF growth 1Y200.69%
OCF growth 3Y-16.31%
OCF growth 5Y-12.05%

CYMBRIA CORP-A / CYB.CA FAQ

Can you describe the business of CYMBRIA CORP-A?

Cymbria Corp is a CA-based company operating in Capital Markets industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2008-11-04. Cymbria Corporation is a Canada-based investment company. The investment objective of the Company is to provide long-term capital appreciation through a concentrated portfolio of global companies and an investment in EdgePoint Wealth Management Inc. (EdgePoint), which offers mutual funds, institutional and other investments through financial advisors. The Company’s investment portfolio also includes Berry Global Group Inc., Norfolk Southern Corporation, Computer Modelling Group Limited, Osisko Gold Royalties Limited, Dollar Tree Inc., Elevance Health Inc., Fairfax Financial Holdings Limited, Mattel Inc., Restaurant Brands International Inc., SAP SE, Dayforce Inc., Koninklijke Philips NV, RB Global Inc., Lincoln Electric Holdings Inc, and others. EdgePoint Investment Group Inc. acts as the manager of the Company.


Can you provide the latest stock price for CYMBRIA CORP-A?

The current stock price of CYB.CA is 87.01 CAD. The price increased by 0.57% in the last trading session.


What is the ChartMill technical and fundamental rating of CYB stock?

CYB.CA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.